
Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global speciality generics market size reached a value of almost USD 64.06 Billion in the year 2024. The industry is further expected to grow at a CAGR of 12.00% between 2025 and 2034 to reach a value of almost USD 198.96 Billion by 2034.
Base Year
Historical Year
Forecast Year
Value in USD Billion
2025-2034
Speciality Generics Market Outlook
*this image is indicative*
The global speciality generics market is driven by the research and development activities, globally. North America is the leading regional market for speciality generics, bolstered by the increasing cases of chronic and complex health conditions such as cancer, epilepsy, HIV, autoimmune diseases, Hepatitis, multiple sclerosis, and rheumatoid arthritis in the region. Speciality generics offer a cost-effective alternative to the branded versions as they do not require costly development and marketing costs, which is further aiding the industry growth.
Speciality generics are referred to as off-patented drugs, which are used to treat chronic or complex health conditions. These drugs require special handling, monitoring, and usually require prior authorisation to order them. Currently, speciality generics are gaining enormous popularity as they are utilised to treat rare chronic diseases like HIV AIDS, cancer, rheumatoid arthritis, and haemophilia.
The speciality generics market is segmented on the basis of route of administration:
Currently, injectables dominate the market across the globe.
On the basis of indication, the speciality generics market is categorised into:
Among all of these, oncology accounts for the majority of the global market share.
On the basis of distribution channel, the industry is divided into:
Presently, the products are majorly distributed through the medium of speciality pharmacies.
On the basis of region, the industry is divided into:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global speciality generics market is driven by the supporting policies and regulations by the governments of several countries to help in the production of speciality generics. In addition to this, speciality generic drugs are less expensive to produce and manufacture as compared to newly patented drugs, as they are not required to go through any clinical trials and approval prior to entering the industry. On account of this, these products offer low risk and high margins in comparison to newly patented drugs, which generally take about 3- 4 years in product development and approval.
The industry is further aided by the rising research and development (R&D) activities to create new and innovative formulations that offer more efficient and cost-effective options as compared to their branded counterparts. Moreover, many companies are expanding their capacities as they are getting involved with mergers and acquisitions (M&A). For instance, Alvogen, a pharmaceutical company, acquired County Line Pharmaceuticals, a company committed to the formulation of speciality generics.
The report gives a detailed analysis of the following key players in the global speciality generics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The global speciality generics market reached a value of USD 64.06 Billion in 2024.
The market is projected to grow at a CAGR of nearly 12.00% in the forecast period of 2025-2034.
The market is estimated to reach a value of about USD 198.96 Billion by 2034.
The major drivers of the industry include the rising disposable incomes, increasing population, research and development activities, and the rising competition among key players.
The rising supporting policies and regulations by the governments are expected to be the key trends guiding the growth of the industry.
North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa are the leading regions in the market, with North America accounting for the largest market share.
Injectables is the dominant route of administration of the product in the market.
Oncology is the leading indication of the product in the industry.
The speciality pharmacies segment accounts for the largest market share, among other distribution channels in the industry.
The leading players in the market are Teva Pharmaceutical Industries Ltd., Mylan N.V., Mallinckrodt plc, Pfizer, Inc., Sun Pharmaceutical Industries Ltd, and Apotex Inc., among others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
REPORT FEATURES | DETAILS |
Base Year | 2024 |
Historical Period | 2018-2024 |
Forecast Period | 2025-2034 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Route of Administration |
|
Breakup by Indication |
|
Breakup by Distribution Channel |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share